PL368722A1 - Sposoby wytwarzania 3-hydroksy-N,1,6-trialkilo-4-okso-1,4-dihydropirydyno-2-karboksyamidu - Google Patents
Sposoby wytwarzania 3-hydroksy-N,1,6-trialkilo-4-okso-1,4-dihydropirydyno-2-karboksyamiduInfo
- Publication number
- PL368722A1 PL368722A1 PL02368722A PL36872202A PL368722A1 PL 368722 A1 PL368722 A1 PL 368722A1 PL 02368722 A PL02368722 A PL 02368722A PL 36872202 A PL36872202 A PL 36872202A PL 368722 A1 PL368722 A1 PL 368722A1
- Authority
- PL
- Poland
- Prior art keywords
- oxo
- dihydropyridine
- trialkyl
- carboxamide
- hydroxy
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 abstract 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000012442 inert solvent Substances 0.000 abstract 1
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 150000003138 primary alcohols Chemical class 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/985,269 US6426418B1 (en) | 2001-11-02 | 2001-11-02 | Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL368722A1 true PL368722A1 (pl) | 2005-04-04 |
Family
ID=25531334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02368722A PL368722A1 (pl) | 2001-11-02 | 2002-10-30 | Sposoby wytwarzania 3-hydroksy-N,1,6-trialkilo-4-okso-1,4-dihydropirydyno-2-karboksyamidu |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US6426418B1 (pl) |
| EP (1) | EP1440061B1 (pl) |
| KR (1) | KR20050056908A (pl) |
| CN (1) | CN1282645C (pl) |
| AT (1) | ATE359272T1 (pl) |
| BR (1) | BR0213814A (pl) |
| DE (1) | DE60219501D1 (pl) |
| ES (1) | ES2284925T3 (pl) |
| MX (1) | MXPA04004063A (pl) |
| PL (1) | PL368722A1 (pl) |
| WO (1) | WO2003037867A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6426418B1 (en) * | 2001-11-02 | 2002-07-30 | Apotex, Inc. | Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide |
| NZ529657A (en) * | 2003-11-20 | 2004-07-30 | Apotex Inc | Iron chelating cycloalkyl derivatives of 3-hydroxy-4-pyridinones |
| CA2488034C (en) * | 2004-11-19 | 2009-10-06 | Apotex Inc. | Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues |
| WO2010011814A1 (en) | 2008-07-25 | 2010-01-28 | Smithkline Beecham Corporation | Chemical compounds |
| WO2010067176A1 (en) * | 2008-12-11 | 2010-06-17 | Shionogi & Co., Ltd. | Maltol ether processes and intermediates |
| KR101733625B1 (ko) | 2008-12-11 | 2017-05-10 | 시오노기세야쿠 가부시키가이샤 | 카르바모일피리돈 ｈｉｖ 인테그라제 억제제 및 중간체의 합성 |
| CN102245572B (zh) | 2008-12-11 | 2015-03-25 | 盐野义制药株式会社 | 氨甲酰基吡啶酮hiv整合酶抑制剂的方法和中间体 |
| TWI518084B (zh) | 2009-03-26 | 2016-01-21 | 鹽野義製藥股份有限公司 | 哌喃酮與吡啶酮衍生物之製造方法 |
| TWI582097B (zh) | 2010-03-23 | 2017-05-11 | Ｖｉｉｖ醫療保健公司 | 製備胺甲醯吡啶酮衍生物及中間體之方法 |
| CN105153421B (zh) * | 2015-07-28 | 2017-10-13 | 辽宁石油化工大学 | 一种制备四甲基哌啶氮氧自由基聚合物方法 |
| CN105294413B (zh) * | 2015-09-17 | 2017-04-12 | 浙江工业大学 | 一种铁盐催化醇氧化制备醛/酮的方法 |
| CN111386276B (zh) * | 2017-10-06 | 2023-06-23 | 盐野义制药株式会社 | 制备取代的多环吡啶酮衍生物的立体选择性方法 |
| CN109438405B (zh) * | 2018-12-24 | 2023-04-07 | 广东莱佛士制药技术有限公司 | 一种3-(苄氧基)-4-氧代-4h-吡喃-2-羧酸的合成方法 |
| US20240174654A1 (en) * | 2021-03-01 | 2024-05-30 | Orion Corporation | Process for the preparation of a cyp11a1 inhibitor and intermediates thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3468915A (en) | 1966-04-18 | 1969-09-23 | Pfizer & Co C | Novel 2-substituted-6-methylpyromeconic acids |
| GR78491B (pl) | 1982-03-24 | 1984-09-27 | Nat Res Dev | |
| GB9217099D0 (en) | 1992-08-12 | 1992-09-23 | British Tech Group | Pharmaceutical compositions |
| ES2244967T3 (es) | 1995-09-29 | 2005-12-16 | Novartis Ag | Nuevas hidroxipiridinonas. |
| GB9711093D0 (en) | 1997-05-29 | 1997-07-23 | British Tech Group | Novel orally active iron (III) chelators |
| EP1070039A1 (en) * | 1998-04-09 | 2001-01-24 | Merck & Co., Inc. | Oxidation process using tempo |
| US6426418B1 (en) * | 2001-11-02 | 2002-07-30 | Apotex, Inc. | Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide |
-
2001
- 2001-11-02 US US09/985,269 patent/US6426418B1/en not_active Expired - Fee Related
-
2002
- 2002-03-19 US US10/100,107 patent/US6476229B1/en not_active Expired - Fee Related
- 2002-03-19 US US10/100,133 patent/US6472532B1/en not_active Expired - Fee Related
- 2002-10-30 WO PCT/CA2002/001623 patent/WO2003037867A1/en not_active Ceased
- 2002-10-30 DE DE60219501T patent/DE60219501D1/de not_active Expired - Lifetime
- 2002-10-30 EP EP02771927A patent/EP1440061B1/en not_active Expired - Lifetime
- 2002-10-30 AT AT02771927T patent/ATE359272T1/de not_active IP Right Cessation
- 2002-10-30 ES ES02771927T patent/ES2284925T3/es not_active Expired - Lifetime
- 2002-10-30 PL PL02368722A patent/PL368722A1/pl not_active Application Discontinuation
- 2002-10-30 MX MXPA04004063A patent/MXPA04004063A/es active IP Right Grant
- 2002-10-30 CN CNB028215672A patent/CN1282645C/zh not_active Expired - Fee Related
- 2002-10-30 BR BR0213814-0A patent/BR0213814A/pt not_active Application Discontinuation
- 2002-10-30 KR KR1020047006656A patent/KR20050056908A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ATE359272T1 (de) | 2007-05-15 |
| WO2003037867A1 (en) | 2003-05-08 |
| EP1440061B1 (en) | 2007-04-11 |
| BR0213814A (pt) | 2004-10-19 |
| CN1578769A (zh) | 2005-02-09 |
| DE60219501D1 (de) | 2007-05-24 |
| MXPA04004063A (es) | 2004-07-08 |
| ES2284925T3 (es) | 2007-11-16 |
| US6426418B1 (en) | 2002-07-30 |
| US6472532B1 (en) | 2002-10-29 |
| EP1440061A1 (en) | 2004-07-28 |
| KR20050056908A (ko) | 2005-06-16 |
| CN1282645C (zh) | 2006-11-01 |
| US6476229B1 (en) | 2002-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL368722A1 (pl) | Sposoby wytwarzania 3-hydroksy-N,1,6-trialkilo-4-okso-1,4-dihydropirydyno-2-karboksyamidu | |
| WO2006004100A8 (ja) | １，２－ジヒドロピリジン－２－オン化合物の製造方法 | |
| DE60311599D1 (de) | Verfahren zur herstellung von duloxetin und deren verwendeten zwischenprodukten | |
| AU7090601A (en) | Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid | |
| SI1601653T1 (sl) | Postopek za pripravo substituiranih estrov nikotinske kisline | |
| WO2002045658A3 (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof | |
| DE60202203D1 (de) | Neues verfahren zur herstellung von oxabispidinen | |
| AU2003213422A1 (en) | PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE | |
| HU0001618D0 (en) | Process for producing a known tetrazole derivative | |
| WO2003048082A3 (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof | |
| CA2367370A1 (en) | Process for the preparation of a diol | |
| AU6474200A (en) | Process for the preparation of a pyridinemethanol compound | |
| WO2002010286A3 (en) | Process for the preparation of carboxylate and phosphonate ruthenium polypyridine dyes and a process for the preparation of reaction intermediates used in such process | |
| CA2412049A1 (en) | Process for the preparation of 5-aminosalicyclic acid | |
| ATE244706T1 (de) | Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung | |
| ATE380171T1 (de) | Verfahren zur herstellung von terbinafine | |
| WO2004029006A3 (en) | Process for the preparation of fluorohaloalkanes | |
| EP1431278A4 (en) | METHOD FOR PRODUCING (2-NITROPHENYL) ACETONITRILE DERIVATIVES AND ASSOCIATED INTERMEDIATES | |
| DE60014103D1 (de) | Verfahren zur herstellung von debromohymenialdisin und deren analogen | |
| DE60133674D1 (de) | Zwischenprodukte für die herstellung von mirtazapin und verfahren zu deren herstellung | |
| EP1634879A4 (en) | METHOD FOR THE SELECTIVE INTRODUCTION OF AN AMINO SUBSTITUENT | |
| CA2399598A1 (en) | Process for preparing aryl-iminomethyl-carbamino acid esters | |
| CA2365083A1 (en) | Process for producing 4,4-dimethyl-3.beta.-hydrocypregna-8,14-diene-21-carboxylic acid esters and intermediate products obtained by said process | |
| MXPA04003629A (es) | Nuevos derivados propionicos beta-fenil-alfa oxisubstituidos: procesos para su preparacion y su uso en la preparacion de compuestos farmaceuticamente importantes. | |
| MXPA04004708A (es) | Proceso para preparacion de 2- o 9-oxa-3,7-diazabiciclo (3.3.1)nonanos a partir de 2-aminometil-2,3-dihidrooxazinas, compuestos intermedios para los mismos y proceso para preparar tales compuestos intermedios. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |